Total Payments
$117,303
2024 Payments
$20.00
Companies
6
Transactions
21
Medicare Patients
2,827
Medicare Billing
$253,626
Payment Breakdown by Category
Research$116,969 (99.7%)
Food & Beverage$313.96 (0.3%)
Education$20.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $116,969 | 11 | 99.7% |
| Food and Beverage | $313.96 | 9 | 0.3% |
| Education | $20.00 | 1 | 0.0% |
Payments by Type
Research
$116,969
11 transactions
General
$333.96
10 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $116,969 | 11 | $0 (2020) |
| Penumbra, Inc. | $110.12 | 1 | $0 (2020) |
| Genentech USA, Inc. | $102.54 | 1 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $74.90 | 5 | $0 (2022) |
| CSL Behring | $34.91 | 2 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $11.49 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $20.00 | 1 | CSL Behring ($20.00) |
| 2022 | $28.44 | 2 | Janssen Pharmaceuticals, Inc ($28.44) |
| 2021 | $16.93 | 1 | Janssen Pharmaceuticals, Inc ($16.93) |
| 2020 | $52,745 | 7 | AbbVie Inc. ($52,605) |
| 2019 | $64,379 | 8 | AbbVie, Inc. ($64,364) |
| 2018 | $114.03 | 2 | Genentech USA, Inc. ($102.54) |
All Payment Transactions
21 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/19/2024 | CSL Behring | Kcentra (Biological) | Education | In-kind items and services | $20.00 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 03/09/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/25/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.55 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/12/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/20/2020 | Penumbra, Inc. | Indigo (Device), Indigo | Food and Beverage | Cash or cash equivalent | $110.12 | General |
| Category: Peripheral Intervention | ||||||
| 07/15/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/10/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/25/2020 | AbbVie Inc. | VENCLEXTA (Drug) | — | Cash or cash equivalent | $34,528.50 | Research |
| Study: M16-043 • Category: ONCOLOGY | ||||||
| 03/24/2020 | AbbVie Inc. | VENCLEXTA (Drug) | — | Cash or cash equivalent | $5,652.00 | Research |
| Study: M16-043 • Category: ONCOLOGY | ||||||
| 02/24/2020 | AbbVie Inc. | VENCLEXTA (Drug) | — | Cash or cash equivalent | $7,101.00 | Research |
| Study: M16-043 • Category: ONCOLOGY | ||||||
| 01/28/2020 | AbbVie Inc. | VENCLEXTA (Drug) | — | Cash or cash equivalent | $5,323.50 | Research |
| Study: M16-043 • Category: ONCOLOGY | ||||||
| 11/06/2019 | CSL Behring | Kcentra (Biological) | Food and Beverage | Cash or cash equivalent | $14.91 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 07/25/2019 | AbbVie, Inc. | Venclexta (Drug) | — | Cash or cash equivalent | $1,795.50 | Research |
| Study: M16-043 • Category: Virology | ||||||
| 06/17/2019 | AbbVie, Inc. | Venclexta (Drug) | — | Cash or cash equivalent | $3,118.50 | Research |
| Study: M16-043 • Category: Virology | ||||||
| 05/23/2019 | AbbVie, Inc. | Venclexta (Drug) | — | Cash or cash equivalent | $788.47 | Research |
| Study: M16-043 • Category: Virology | ||||||
| 04/25/2019 | AbbVie, Inc. | Venclexta (Drug) | — | Cash or cash equivalent | $35,815.50 | Research |
| Study: M16-043 • Category: Virology | ||||||
| 04/25/2019 | AbbVie, Inc. | Venclexta (Drug) | — | Cash or cash equivalent | $6,063.75 | Research |
| Study: M16-043 • Category: Virology | ||||||
| 04/25/2019 | AbbVie, Inc. | Venclexta (Drug) | — | Cash or cash equivalent | $5,618.25 | Research |
| Study: M16-043 • Category: Virology | ||||||
| 04/22/2019 | AbbVie, Inc. | Venclexta (Drug) | — | Cash or cash equivalent | $11,164.50 | Research |
| Study: M16-043 • Category: Virology | ||||||
| 10/16/2018 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $102.54 | General |
| 04/16/2018 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $11.49 | General |
| Category: Cardiovascular and Metabolism | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| M16-043 | AbbVie, Inc. | $64,364 | 7 |
| M16-043 | AbbVie Inc. | $52,605 | 4 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 390 | 421 | $373,831 | $44,312 |
| 2022 | 5 | 751 | 859 | $796,790 | $71,184 |
| 2021 | 6 | 876 | 1,018 | $788,936 | $74,145 |
| 2020 | 6 | 810 | 905 | $689,673 | $63,985 |
Total Patients
2,827
Total Services
3,203
Medicare Billing
$253,626
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 218 | 229 | $260,241 | $30,118 | 11.6% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 103 | 108 | $81,066 | $9,368 | 11.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 16 | 16 | $9,808 | $2,727 | 27.8% |
| 99283 | Emergency department visit with low level of medical decision making | Facility | 2023 | 22 | 35 | $19,977 | $1,903 | 9.5% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 31 | 33 | $2,739 | $196.18 | 7.2% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 337 | 369 | $569,316 | $51,417 | 9.0% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 138 | 146 | $150,461 | $13,664 | 9.1% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 45 | 79 | $54,688 | $4,433 | 8.1% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 216 | 250 | $20,750 | $1,568 | 7.6% |
| 71045 | X-ray of chest, 1 view | Facility | 2022 | 15 | 15 | $1,575 | $102.89 | 6.5% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 343 | 363 | $543,043 | $51,769 | 9.5% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 128 | 131 | $132,004 | $12,704 | 9.6% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 44 | 86 | $58,081 | $4,852 | 8.4% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 333 | 409 | $33,947 | $2,611 | 7.7% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 11 | 11 | $20,061 | $2,091 | 10.4% |
| 71045 | X-ray of chest, 1 view | Facility | 2021 | 17 | 18 | $1,800 | $119.00 | 6.6% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 337 | 353 | $508,067 | $48,113 | 9.5% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 81 | 81 | $78,372 | $7,679 | 9.8% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 44 | 61 | $39,517 | $3,101 | 7.8% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 14 | 14 | $24,644 | $2,479 | 10.1% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 311 | 373 | $36,883 | $2,450 | 6.6% |
| 71045 | X-ray of chest, 1 view | Facility | 2020 | 23 | 23 | $2,190 | $164.43 | 7.5% |
About Dr. Mark Sloan, M.D
Dr. Mark Sloan, M.D is a Emergency Medicine healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/28/2009. The National Provider Identifier (NPI) number assigned to this provider is 1992938625.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Sloan, M.D has received a total of $117,303 in payments from pharmaceutical and medical device companies, with $20.00 received in 2024. These payments were reported across 21 transactions from 6 companies. The most common payment nature is "" ($116,969).
As a Medicare-enrolled provider, Sloan has provided services to 2,827 Medicare beneficiaries, totaling 3,203 services with total Medicare billing of $253,626. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Emergency Medicine
- Location Lexington, KY
- Active Since 08/28/2009
- Last Updated 04/03/2023
- Taxonomy Code 207P00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1992938625
Products in Payments
- Venclexta (Drug) $64,364
- VENCLEXTA (Drug) $52,605
- Indigo (Device) $110.12
- XARELTO (Drug) $74.90
- Kcentra (Biological) $34.91
- BRILINTA (Drug) $11.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Lexington
Dr. Ryan Stanton, Md, MD
Emergency Medicine — Payments: $106,923
Emergency Medicine $106,923
Robert Bartlett, M.d, M.D
Emergency Medicine — Payments: $68,609
Emergency Medicine $68,609
Douglas Smith, Md, MD
Emergency Medicine — Payments: $37,112
Emergency Medicine $37,112
Sameer Desai, Md, MD
Emergency Medicine — Payments: $29,307
Emergency Medicine $29,307
Dr. Patrick O'malley, Md, MD
Emergency Medicine — Payments: $22,653
Emergency Medicine $22,653
Dr. Dennis Orr, Do, DO
Emergency Medicine — Payments: $13,997
Emergency Medicine $13,997